Product NDC: | 59310-210 |
Proprietary Name: | QNASL |
Non Proprietary Name: | beclomethasone dipropionate |
Active Ingredient(s): | 80 ug/1 & nbsp; beclomethasone dipropionate |
Administration Route(s): | NASAL |
Dosage Form(s): | AEROSOL, METERED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 59310-210 |
Labeler Name: | Teva Respiratory, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA202813 |
Marketing Category: | NDA |
Start Marketing Date: | 20120405 |
Package NDC: | 59310-210-14 |
Package Description: | 120 AEROSOL, METERED in 1 INHALER (59310-210-14) |
NDC Code | 59310-210-14 |
Proprietary Name | QNASL |
Package Description | 120 AEROSOL, METERED in 1 INHALER (59310-210-14) |
Product NDC | 59310-210 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | beclomethasone dipropionate |
Dosage Form Name | AEROSOL, METERED |
Route Name | NASAL |
Start Marketing Date | 20120405 |
Marketing Category Name | NDA |
Labeler Name | Teva Respiratory, LLC |
Substance Name | BECLOMETHASONE DIPROPIONATE |
Strength Number | 80 |
Strength Unit | ug/1 |
Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |